Pyrimidine derivatives as kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8519129
APP PUB NO 20110112063A1
SERIAL NO

13000955

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides novel pyrimidine derivatives of formula I and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of insulin-like growth factor (IGF-IR) or analplastic lymphoma kinase (ALK).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IRM LLCBERMUDA (UK) HAMILTON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Bei San Diego, US 110 878
He, Xiaohui San Diego, US 32 335
Jiang, Songchun San Diego, US 38 346
Lee, Christian Cho-Hua San Diego, US 7 51
Lu, Wenshuo San Diego, US 19 216
Marsilje,, III Thomas H San Diego, US 7 40
Yang, Kunyong San Diego, US 18 240

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 27, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00